Xencor (NASDAQ:XNCR) Issues Earnings Results, Misses Expectations By $0.67 EPS

Xencor (NASDAQ:XNCR – Get Free Report) posted its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.67), Briefing.com reports. The business had revenue of $44.70 million during the quarter, compared to the consensus estimate of $77.63 million. Xencor had a […]

Related Keywords

Blackrock ,Nova Scotia ,Canada ,Bassili Dahiyat ,Johnr Desjarlais ,Piper Sandler ,Securities Exchange Commission ,Xencor Company Profile ,Xencor Inc ,Vanguard Group Inc ,Royal Bank ,Pricet Rowe Associates Inc ,Blackrock Inc ,Get Free Report ,Exchange Commission ,State Street Corp ,Street Corp ,Xencor Daily ,Xencor ,Nasdaq Xncr ,Xncr ,Medical ,Earnings ,